Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

LifeStance Health Gr Affirms FY2025 Sales Guidance of $1.40B-$1.44B vs $1.42B Est

Author: Benzinga Newsdesk | May 07, 2025 06:11am
LifeStance Health Gr (NASDAQ:LFST) affirms FY2025 sales outlook from $1.40 billion-$1.44 billion to $1.40 billion-$1.44 billion vs $1.42 billion estimate.

Posted In: LFST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist